Quick Answer ALBEMARLE CORP reported R&D Expense of $51.40 million for fiscal year 2025. ALBEMARLE CORP R&D Expense — Annual History Fiscal Year R&D Expense YoY Change 2025 $51.40M -40.7% 2024 $86.72M +1.2% 2023 $85.72M +19.1% 2022 $71.98M +33.2% 2021 $54.03M -8.8% 2020 $59.21M +1.6% 2019 $58.29M -16.8% 2018 $70.05M -16.9% 2017 $84.33M +4.8% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Operating Income of -$367.08 million for fiscal year 2025. ALBEMARLE CORP Operating Income — Annual History Fiscal Year Operating Income YoY Change 2025 -$367.08M +79.3% 2024 -$1.78B -805.3% 2023 $251.88M -89.8% 2022 $2.47B +209.4% 2021 $798.43M +57.9% 2020 $505.81M -24.1% 2019 $666.12M -26.9% 2018 $911.54M +59.5% 2017 $571.66M -4.9% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Stockholders Equity of $9.53 billion for fiscal year 2025. ALBEMARLE CORP Stockholders Equity — Annual History Fiscal Year Stockholders Equity YoY Change 2025 $9.53B -4.3% 2024 $9.96B +5.8% 2023 $9.41B +17.9% 2022 $7.98B +41.9% 2021 $5.63B +31.8% 2020 $4.27B +8.5% 2019 $3.93B +9.7% 2018 $3.59B -2.4% 2017 $3.67B -3.2% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Long-Term Debt of $3.12 billion for fiscal year 2025. ALBEMARLE CORP Long-Term Debt — Annual History Fiscal Year Long-Term Debt YoY Change 2025 $3.12B +0.0% 2024 $3.12B -11.9% 2023 $3.54B +10.1% 2022 $3.21B +60.4% 2021 $2.00B -27.6% 2020 $2.77B -3.3% 2019 $2.86B +104.8% 2018 $1.40B -1.2% 2017 $1.42B -33.3% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Cash and Equivalents of $613.11 million for fiscal year 2019. ALBEMARLE CORP Cash and Equivalents — Annual History Fiscal Year Cash and Equivalents YoY Change 2019 $613.11M +10.4% 2018 $555.32M -51.2% 2017 $1.14B -49.9% 2016 $2.27B +962.0% 2015 $213.73M -91.4% 2014 $2.49B +421.7% 2013 $477.24M -0.1% 2012 $477.70M +1.8% 2011 … Read more
Quick Answer ALBEMARLE CORP reported Total Assets of $16.37 billion for fiscal year 2025. ALBEMARLE CORP Total Assets — Annual History Fiscal Year Total Assets YoY Change 2025 $16.37B -1.4% 2024 $16.61B -9.1% 2023 $18.27B +18.2% 2022 $15.46B +40.8% 2021 $10.97B +5.0% 2020 $10.45B +6.0% 2019 $9.86B +30.1% 2018 $7.58B -2.2% 2017 $7.75B -5.0% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Diluted EPS of $5.76 per share (loss) for fiscal year 2025. ALBEMARLE CORP Diluted EPS — Annual History Fiscal Year Diluted EPS YoY Change 2025 -$5.76 +48.6% 2024 -$11.20 -183.8% 2023 $13.36 -41.5% 2022 $22.84 +2054.7% 2021 $1.06 -69.9% 2020 $3.52 -29.9% 2019 $5.02 -20.8% 2018 $6.34 +1193.9% 2017 $0.49 … Read more
Quick Answer ALBEMARLE CORP reported Net Income of -$510.63 million for fiscal year 2025. ALBEMARLE CORP Net Income — Annual History Fiscal Year Net Income YoY Change 2025 -$510.63M +56.7% 2024 -$1.18B -175.0% 2023 $1.57B -41.5% 2022 $2.69B +2075.0% 2021 $123.67M -67.1% 2020 $375.76M -29.5% 2019 $533.23M -23.1% 2018 $693.56M +1164.5% 2017 $54.85M -91.5% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Total Revenue of $5.14 billion for fiscal year 2025. ALBEMARLE CORP Total Revenue — Annual History Fiscal Year Total Revenue YoY Change 2025 $5.14B -4.4% 2024 $5.38B -44.1% 2023 $9.62B +31.4% 2022 $7.32B +120.0% 2021 $3.33B +6.4% 2020 $3.13B -12.8% 2019 $3.59B +6.4% 2018 $3.37B +9.9% 2017 $3.07B +14.7% 2016 … Read more
Quick Answer ALBEMARLE CORP reported Total Revenue of $5.14 billion for fiscal year 2025. ALBEMARLE CORP — Key Financials by Year Metric 2025 2024 2023 2022 2021 2020 Total Revenue $5.14B-4.4% $5.38B-44.1% $9.62B+31.4% $7.32B+120.0% $3.33B+6.4% $3.13B-12.8% Net Income -$510.63M+56.7% -$1.18B-175.0% $1.57B-41.5% $2.69B+2075.0% $123.67M-67.1% $375.76M-29.5% Diluted EPS -$5.76+48.6% -$11.20-183.8% $13.36-41.5% $22.84+2054.7% $1.06-69.9% $3.52-29.9% Total Assets $16.37B-1.4% … Read more